NCT04495972View on ClinicalTrials.gov

Intestinimonas for Prevention of Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

September 12, 2023

Study Completion Date

November 10, 2023

Conditions
PreDiabetes
Interventions
DIETARY_SUPPLEMENT

Intestinimonas-capsules

Capsules containing microbiota (Intestinimonas)

DIETARY_SUPPLEMENT

Placebo-capsules

Placebo capsules are identical to the active treatment

Trial Locations (1)

Unknown

University Piemonte Orientale, Vercelli

Sponsors
All Listed Sponsors
lead

Caelus Pharmaceuticals BV

INDUSTRY

NCT04495972 - Intestinimonas for Prevention of Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter